Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoids

Mohamed Elbadawy(Benha University), Kazuaki Sasaki(Tokyo University of Agriculture and Technology)
Frontiers in Pharmacology
October 12, 2023
Cited by 25


Related Papers